Biggest News Aggregation in the World
๐Ÿ“ฐ Oak News

Page 89 - Oak News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Oak. Real-time updates on events, politics, business and more.

Takeda Reports Positive Topline Results Of Phase 2b Study Of TAK-279 For Active Psoriatic Arthritis

Takeda Pharmaceutical Co. Ltd. (TAK, TKPHF.PK) announced Monday positive topline results from its randomized, double-blind, placebo-controlled, multiple-dose Phase 2b trial evaluating TAK-279, an investigational oral allosteric tyrosine kinase 2 (TYK2) inhibitor with next generation selectivity, in people with active psoriatic arthritis.
Takeda Pharmaceutical Co Takeda Pharmaceutical Tak 279

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science